Comparison of four methods to assess high-on platelet reactivity under P2Y12 receptor inhibitor

P2Y12 receptor inhibitors are antiplatelet agents commonly prescribed in the treatment of coronary artery disease. Their efficacy can be limited by high on-treatment platelet reactivity (HPR), which can be evaluated by different biological assays. Most commonly, HPR is evaluated by flow cytometric v...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Fanny Mingant, Romain Didier, Martine Gilard, Françoise Martin, Pierre-Philippe Nicol, Valérie Ugo, Eric Lippert, Hubert Galinat
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Taylor & Francis Group 2018-04-01
Colecção:	Platelets
Assuntos:	high on-treatment platelet reactivity (hpr) light transmittance aggregometry (lta) multiple electrode aggregometry (mea) p2y12 receptor inhibitors platelet function analyzer (pfa) vasodilator-stimulated phosphoprotein (vasp)
Acesso em linha:	http://dx.doi.org/10.1080/09537104.2018.1453058
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!